Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, |
RCV001095475 | SCV001251020 | likely pathogenic | Amyotrophic lateral sclerosis type 12 | 2020-03-31 | criteria provided, single submitter | research | |
Institute of Medical Genetics and Applied Genomics, |
RCV001267917 | SCV001446427 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics Munich, |
RCV001095475 | SCV002764815 | pathogenic | Amyotrophic lateral sclerosis type 12 | 2020-12-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001267917 | SCV002821495 | pathogenic | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | OPTN: PVS1, PM3:Strong, PP1:Strong, PM2 |
Human Genetics Bochum, |
RCV001095475 | SCV004042803 | pathogenic | Amyotrophic lateral sclerosis type 12 | 2023-08-16 | criteria provided, single submitter | clinical testing | ACMG criteria used to clasify this variant:PVS1, PS4_SUP, PM2_SUP, PP1 |
Labcorp Genetics |
RCV003769036 | SCV004570126 | pathogenic | Primary open angle glaucoma; Amyotrophic lateral sclerosis type 12; Glaucoma 1, open angle, E | 2024-04-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys360Valfs*18) in the OPTN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OPTN are known to be pathogenic (PMID: 20428114). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal recessive amyotrophic lateral sclerosis (PMID: 25681989). This variant is also known as deltaAA del at P.359*. ClinVar contains an entry for this variant (Variation ID: 873266). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |